What are the treatment options for menstrual migraines?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Menstrual Migraine

For menstrual migraine, start with NSAIDs (ibuprofen 400-800mg or naproxen 275-550mg) or triptans (rizatriptan 10mg, sumatriptan 50-100mg) as acute therapy, and if attacks remain disabling despite optimal acute treatment, add perimenstrual prophylaxis with frovatriptan 2.5mg twice daily or naratriptan 1mg twice daily starting 2 days before expected menstruation for 5 days. 1

Acute Treatment Approach

First-Line Acute Therapy

  • NSAIDs are the initial treatment for mild-to-moderate menstrual migraine attacks 2
    • Ibuprofen 400-800mg every 6 hours (maximum 2.4g/day) 2
    • Naproxen sodium 275-550mg every 2-6 hours (maximum 1.5g/day) 2
    • Diclofenac potassium 2, 1
  • Take NSAIDs early when headache is still mild for maximum effectiveness 1
  • NSAIDs are particularly appropriate when dysmenorrhea coexists, as prostaglandins play a role in both conditions 3

Second-Line Acute Therapy

  • Triptans should be used when NSAIDs provide inadequate relief 2, 1
  • Rizatriptan 10mg has the strongest evidence for acute menstrual migraine treatment, with pain-free responses of 33-73% at 2 hours and sustained pain relief of 63% between 2-24 hours 4
  • Sumatriptan 50-100mg is equally effective (50mg and 100mg show no significant difference in efficacy) 5, 6
  • Combination sumatriptan 85mg/naproxen 500mg prevents recurrence better than either alone 1, 6
  • Take triptans early when headache is mild, not during aura phase 2

Adjunctive Therapy

  • Metoclopramide or prochlorperazine for nausea/vomiting 2, 1
  • Avoid opioids and barbiturates due to dependency risk, rebound headaches, and poor efficacy 2, 1

Perimenstrual Prophylaxis (Short-Term Prevention)

Indications: When acute treatment alone is insufficient to control disability from predictable menstrual attacks 1, 3

Triptan-Based Prophylaxis

  • Frovatriptan 2.5mg twice daily for 6 days (starting 2 days before expected menstruation) has the most robust evidence with four randomized controlled trials 1, 4
  • Naratriptan 1mg twice daily for 5-6 days (starting 2 days before menses) 1, 6, 4
  • Zolmitriptan 2.5mg three times daily 4
  • This approach can reduce headache frequency by approximately 50% 3

NSAID-Based Prophylaxis

  • Naproxen sodium 550mg twice daily starting 2 days before expected menstruation for 5 days 1
  • Mefenamic acid 500mg 6
  • Particularly useful when hormonal strategies are contraindicated 3

Hormonal Prophylaxis

  • Transcutaneous estradiol 1.5mg daily (gel or patch) applied perimenstrually has grade B evidence for women with pure menstrual migraine 2, 6
  • Continuous combined hormonal contraceptives (extended-dosing strategy) can reduce hormone fluctuations and benefit women with pure menstrual migraine without aura 1, 3, 7
  • Contraindicated in migraine with aura due to increased stroke risk 1

Daily Preventive Therapy

When migraines occur frequently throughout the month, not just menstrually 1

  • Beta-blockers (propranolol 120-240mg daily) 2, 1
  • Candesartan 1
  • Topiramate (has least effect on oral contraceptives at doses <200mg/day) 4
  • Avoid combining antiepileptic preventives with hormonal treatments due to enzyme induction affecting contraceptive efficacy 4

Treatment Selection Algorithm

  1. Determine attack pattern: Use 3-month headache diary to confirm predictable menstrual relationship 8
  2. Start with acute therapy: NSAIDs for mild-moderate attacks; triptans for moderate-severe or NSAID-refractory attacks 1
  3. Evaluate response at 2-3 months using headache calendars and mTOQ-4 questionnaire 1
  4. Add perimenstrual prophylaxis if:
    • Attacks remain disabling despite optimal acute treatment 1
    • Menstrual pattern is highly predictable 3, 8
    • Choose frovatriptan or naratriptan (strongest evidence) or naproxen if triptans contraindicated 1, 6
  5. Consider daily prevention if:
    • Migraines occur frequently outside menstrual window 1
    • Perimenstrual prophylaxis fails 1

Critical Pitfalls

  • Do not use triptans during aura phase - they are ineffective and should only be used when headache begins 2
  • Do not prescribe hormonal contraceptives to women with migraine with aura - stroke risk is significantly elevated 1
  • Monitor for medication overuse - limit triptan use and educate patients on rebound headache risk 2
  • Ensure adequate trial duration - perimenstrual prophylaxis requires at least 2-3 menstrual cycles to assess efficacy 1
  • Account for drug interactions - antiepileptic preventives (except topiramate <200mg/day) significantly reduce oral contraceptive efficacy 4

References

Guideline

Menstrual Migraine Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Menstrual Migraine.

Current treatment options in neurology, 2004

Research

Advanced strategies of short-term prophylaxis in menstrual migraine: state of the art and prospects.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.